GASTROINTESTINAL NEUROENDOCRINE TUMOR
Clinical trials for GASTROINTESTINAL NEUROENDOCRINE TUMOR explained in plain language.
Never miss a new study
Get alerted when new GASTROINTESTINAL NEUROENDOCRINE TUMOR trials appear
Sign up with your email to follow new studies for GASTROINTESTINAL NEUROENDOCRINE TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug ESK981 takes on tough cancers in Mid-Stage trial
Disease control Recruiting nowThis study tests an experimental drug called ESK981 in people with advanced pancreatic cancer, certain neuroendocrine tumors, or neuroendocrine prostate cancer. Participants take ESK981 capsules in a 5-days-on, 2-days-off cycle. The main goal is to see if the drug can keep the ca…
Matched conditions: GASTROINTESTINAL NEUROENDOCRINE TUMOR
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New drug BL-M14D1 targets tough cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new drug called BL-M14D1 in people with advanced small cell lung cancer or other neuroendocrine cancers that have spread. The main goals are to check safety, find the right dose, and see if the drug shrinks tumors. About 120 adults will take part.
Matched conditions: GASTROINTESTINAL NEUROENDOCRINE TUMOR
Phase: PHASE1 • Sponsor: SystImmune Inc. • Aim: Disease control
Last updated May 11, 2026 20:52 UTC